Natixis Advisors, L.P. Eli Lilly & CO Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

A detailed history of Natixis Advisors, L.P. transactions in Eli Lilly & CO stock. As of the latest transaction made, Natixis Advisors, L.P. holds 530,713 shares of LLY stock, worth $422 Million. This represents 0.92% of its overall portfolio holdings.

Number of Shares

530,713

Previous 531,048 0.06%

Holding current value

$422 Million

Previous $481 Million 2.21%

% of portfolio

0.92%

Previous 1.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $258,666 - $321,606	-335 Reduced 0.06%	530,713 $470 Million
Q2 2024 Aug 01, 2024	SELL	$724.87 - $909.04 $459,567 - $576,331	-634 Reduced 0.12%	531,048 $481 Million
Q1 2024 Apr 25, 2024	BUY	$592.2 - $792.28 $14.5 Million - $19.4 Million	24,536 Added 4.84%	531,682 $414 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $17.2 Million - $20.2 Million	32,690 Added 6.89%	507,146 $296 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $19.4 Million - $26.8 Million	-44,719 Reduced 8.61%	474,456 $255 Million
Q2 2023 Aug 15, 2023	BUY	$350.74 - $468.98 $8.92 Million - $11.9 Million	25,419 Added 5.15%	519,175 $243 Million
Q1 2023 May 11, 2023	SELL	$310.63 - $364.82 $249,435 - $292,950	-803 Reduced 0.16%	493,756 $170 Million
Q4 2022 Jan 27, 2023	BUY	$321.55 - $374.67 $18.2 Million - $21.2 Million	56,495 Added 12.9%	494,559 $181 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $4.09 Million - $4.67 Million	13,808 Added 3.25%	438,064 $142 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $10 Million - $11.8 Million	35,995 Added 9.27%	424,256 $138 Million
Q1 2022 May 12, 2022	BUY	$234.69 - $291.66 $38.8 Million - $48.3 Million	165,469 Added 74.27%	388,261 $111 Million
Q4 2021 Feb 08, 2022	BUY	$224.85 - $279.04 $7.65 Million - $9.49 Million	34,025 Added 18.02%	222,792 $61.5 Million
Q3 2021 Nov 15, 2021	BUY	$221.6 - $272.71 $2.99 Million - $3.68 Million	13,495 Added 7.7%	188,767 $43.6 Million
Q2 2021 Aug 12, 2021	BUY	$180.55 - $233.54 $4.22 Million - $5.46 Million	23,367 Added 15.38%	175,272 $40.2 Million
Q1 2021 May 05, 2021	BUY	$164.32 - $212.72 $3.46 Million - $4.48 Million	21,044 Added 16.08%	151,905 $28.4 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $682,697 - $903,372	5,233 Added 4.17%	130,861 $22.1 Million
Q3 2020 Nov 12, 2020	SELL	$146.22 - $169.13 $1.48 Million - $1.72 Million	-10,144 Reduced 7.47%	125,628 $18.6 Million
Q2 2020 Aug 11, 2020	BUY	$136.42 - $164.18 $1.48 Million - $1.78 Million	10,833 Added 8.67%	135,772 $22.3 Million
Q1 2020 Apr 27, 2020	BUY	$119.05 - $147.35 $4.66 Million - $5.77 Million	39,182 Added 45.69%	124,939 $17.3 Million
Q4 2019 Feb 10, 2020	BUY	$106.92 - $132.43 $552,027 - $683,736	5,163 Added 6.41%	85,757 $11.3 Million
Q3 2019 Nov 12, 2019	BUY	$106.79 - $116.16 $1.06 Million - $1.15 Million	9,941 Added 14.07%	80,594 $9.01 Million
Q2 2019 Aug 12, 2019	SELL	$110.79 - $129.32 $421,888 - $492,450	-3,808 Reduced 5.11%	70,653 $7.83 Million
Q1 2019 May 15, 2019	BUY	$111.31 - $131.02 $541,411 - $637,281	4,864 Added 6.99%	74,461 $9.66 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $1.59 Million - $1.78 Million	15,037 Added 27.56%	69,597 $8.05 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $687,824 - $859,660	8,011 Added 17.21%	54,560 $5.86 Million
Q2 2018 Aug 14, 2018	BUY	$75.7 - $86.88 $482,663 - $553,946	6,376 Added 15.87%	46,549 $0
Q1 2018 May 10, 2018	SELL	$74.21 - $87.6 $171,796 - $202,794	-2,315 Reduced 5.45%	40,173 $3.11 Million
Q4 2017 Feb 14, 2018	BUY	$81.94 - $87.89 $238,281 - $255,584	2,908 Added 7.35%	42,488 $3.59 Million
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $3.05 Million - $3.39 Million	39,580	39,580 $3.39 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account

Natixis Advisors, L.P. Eli Lilly & CO Transaction History